Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
Antwerp University Hospital · Helsinki University Hospital · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,493
total citations
- FWCI
- 179.13
- Percentile
- 100%
- References
- 42
Citations per year
Authors
5Topics & keywords
Topics
Keywords
- Rimonabant
- Medicine
- Placebo
- Overweight
- Internal medicine
- Population
- Body mass index
- Weight loss
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.